IRL201104

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
98	好酸球性消化管疾患	1

98. 好酸球性消化管疾患

臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05084963 (ClinicalTrials.gov)	October 29, 2021	30/9/2021	A Study to Assess the Efficacy, Safety and Tolerability of IRL201104in Adults With Active Eosinophil ...	A Phase 2a, Double-blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and ...	Eosinophilic Esophagitis	Drug: IRL201104;Drug: Placebo	Revolo Biotherapeutics	NULL	Completed	18 Years	75 Years	All	36	Phase 2	United States

First Previous1Next Last